|
US213668A
(en)
|
|
1879-03-25 |
|
Improvement in ice-making apparatus |
|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
JPS5452794A
(en)
|
1977-09-30 |
1979-04-25 |
Kousaku Yoshida |
Extracting of polysacchride from capusle containing epidermis staphylococus
|
|
US4285936A
(en)
|
1979-12-10 |
1981-08-25 |
The United States Of America As Represented By The Secretary Of The Army |
Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa
|
|
US4355023A
(en)
|
1980-09-30 |
1982-10-19 |
The Massachusetts General Hospital |
Antibody fragment compositions and process
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4443549A
(en)
|
1981-10-19 |
1984-04-17 |
Molecular Genetics, Inc. |
Production of monoclonal antibodies against bacterial adhesins
|
|
US4470925A
(en)
|
1982-05-05 |
1984-09-11 |
E. I. Du Pont De Nemours And Company |
Immunoglobulin half-molecules and process for producing hybrid antibodies
|
|
US4462334A
(en)
|
1982-08-19 |
1984-07-31 |
Kim Ho K |
Solar animal structure
|
|
US4465776A
(en)
*
|
1982-09-27 |
1984-08-14 |
Research Corporation |
Monoclonal antibodies to vitamin B6 and immunoassay method
|
|
US4652448A
(en)
|
1982-10-07 |
1987-03-24 |
Molecular Genetics, Inc. |
Use of monoclonal antibodies against bacterial adhesins
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4578458A
(en)
|
1983-03-23 |
1986-03-25 |
Brigham And Women's Hospital |
Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa
|
|
DK219084D0
(da)
|
1984-05-02 |
1984-05-02 |
Frederik Carl Peter Lindberg |
Antigen
|
|
JPS6191131A
(ja)
|
1984-10-09 |
1986-05-09 |
Chugai Pharmaceut Co Ltd |
医薬品の吸着防止方法および組成物
|
|
GB8426463D0
(en)
|
1984-10-19 |
1984-11-28 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
|
NZ214503A
(en)
|
1984-12-20 |
1990-02-26 |
Merck & Co Inc |
Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
|
|
FR2581877B1
(fr)
|
1985-05-14 |
1987-12-18 |
Louvain Universite Catholique |
Conjugue constitue d'une adhesine de paroi de s. mutans, de nature proteique et d'un polysaccharide de s. mutans, sa preparation et son utilisation notamment dans des vaccins anti-caries
|
|
US4786592A
(en)
|
1986-06-18 |
1988-11-22 |
Scripps Clinic And Research Foundation |
Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
|
|
US5589591A
(en)
|
1986-07-03 |
1996-12-31 |
Advanced Magnetics, Inc. |
Endotoxin-free polysaccharides
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8621910D0
(en)
|
1986-09-11 |
1986-10-15 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
FR2619122B1
(fr)
|
1987-08-03 |
1990-03-09 |
Pasteur Institut |
Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
|
|
US4859449A
(en)
|
1987-09-14 |
1989-08-22 |
Center For Molecular Medicine And Immunology |
Modified antibodies for enhanced hepatocyte clearance
|
|
CA1340506C
(en)
|
1987-11-24 |
1999-04-20 |
Nicholas H. Carbonetti |
Production of gonorrheal pi proteins and vaccines
|
|
US5055455A
(en)
|
1988-09-28 |
1991-10-08 |
Brigham And Women's Hospital |
Capsular polysaccharide adhesin antigen, preparation, purification and use
|
|
US5211657A
(en)
|
1988-11-07 |
1993-05-18 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
|
|
FR2640628A1
(fr)
|
1988-12-16 |
1990-06-22 |
Commissariat Energie Atomique |
Oligosaccharides lies (beta)-(1 -> 6) en particulier des 2-acetamido-2-desoxy-glucoses ou - galactoses et leur preparation
|
|
JP3436756B2
(ja)
|
1988-12-19 |
2003-08-18 |
アメリカン・サイアナミド・カンパニー |
髄膜炎菌のクラスｉの外膜タンパク質のワクチン
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5571511A
(en)
|
1990-10-22 |
1996-11-05 |
The U.S. Government |
Broadly reactive opsonic antibodies that react with common staphylococcal antigens
|
|
DK0594743T3
(da)
|
1991-07-12 |
1999-12-20 |
Pfizer |
Kontinuert cellelinje og vaccine mod aviær coccidia
|
|
DE69233012T2
(de)
|
1991-11-22 |
2003-11-06 |
Fattom, Ali Ibrahim |
Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
|
|
US5407686A
(en)
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
US5872215A
(en)
*
|
1991-12-02 |
1999-02-16 |
Medical Research Council |
Specific binding members, materials and methods
|
|
ATE156368T1
(de)
|
1991-12-06 |
1997-08-15 |
North Shore Univ Hospital |
Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
|
|
DK0635132T4
(da)
|
1992-03-19 |
2008-08-25 |
Jackson H M Found Military Med |
Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener
|
|
US5362754A
(en)
|
1992-11-12 |
1994-11-08 |
Univ. Of Tx Md Anderson Cancer Center |
M-EDTA pharmaceutical preparations and uses thereof
|
|
US5688516A
(en)
|
1992-11-12 |
1997-11-18 |
Board Of Regents, The University Of Texas System |
Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
|
|
WO1994015640A1
(en)
|
1993-01-12 |
1994-07-21 |
Anthony George Gristina |
Methods and compositions for the direct concentrated delivery of passive immunity
|
|
US5718694A
(en)
|
1993-11-09 |
1998-02-17 |
The Board Of Regents Of The University Of Nebraska |
Inhibition of adherence of microorganisms to biomaterial surfaces by treatment with carbohydrates
|
|
US5858350A
(en)
|
1993-12-01 |
1999-01-12 |
Marine Polymer Technologies |
Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
|
|
EP0804249A2
(en)
|
1994-03-15 |
1997-11-05 |
Brown University Research Foundation |
Polymeric gene delivery system
|
|
CZ292061B6
(cs)
*
|
1994-03-17 |
2003-07-16 |
Merck Patent Gmbh |
Jednořetězcové fragmenty protilátek a protilátky proti receptoru epidermálního růstového faktoru, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
|
|
US5945311A
(en)
|
1994-06-03 |
1999-08-31 |
GSF--Forschungszentrumfur Umweltund Gesundheit |
Method for producing heterologous bi-specific antibodies
|
|
JPH0840932A
(ja)
|
1994-07-29 |
1996-02-13 |
Kitasato Inst:The |
スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US5830539A
(en)
|
1995-11-17 |
1998-11-03 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Methods for functionalizing and coating substrates and devices made according to the methods
|
|
US6245735B1
(en)
|
1996-07-29 |
2001-06-12 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating pseudomonas infection
|
|
ATE218143T1
(de)
|
1996-09-03 |
2002-06-15 |
Gsf Forschungszentrum Umwelt |
Verwendung bi-und trispezifischer antikörper zur induktion einer tumorimmunität
|
|
SK40599A3
(en)
*
|
1996-09-26 |
2000-06-12 |
Chugai Pharmaceutical Co Ltd |
Antibody against human parathormone related peptides
|
|
US6235883B1
(en)
*
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
TW586934B
(en)
|
1997-05-19 |
2004-05-11 |
Sumitomo Pharma |
Immunopotentiating composition
|
|
US5989542A
(en)
|
1997-08-20 |
1999-11-23 |
Brigham And Women's Hospital, Inc. |
Capsular polysaccharides from enterococci
|
|
IT1298539B1
(it)
|
1998-02-03 |
2000-01-12 |
Bracco Spa |
Metodo per la determinazione di infezioni da protesi
|
|
JP2002511259A
(ja)
*
|
1998-04-09 |
2002-04-16 |
ジェンセット |
５’ｅｓｔおよびコードされるヒトタンパク質
|
|
AU4919699A
(en)
|
1998-07-11 |
2000-02-01 |
Mhm Holdings Limited |
Vehicle seat, vehicle seat table and vehicle communication system
|
|
EP1096952B1
(en)
*
|
1998-07-15 |
2008-05-21 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
US7252828B2
(en)
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
CA2356849C
(en)
|
1998-12-16 |
2008-06-03 |
Sca Hygiene Products Zeist B.V. |
Acidic superabsorbent polysaccharides
|
|
WO2002094983A2
(en)
*
|
2001-05-16 |
2002-11-28 |
The Children's Hospital Of Philadelphia |
Dna-antibody complexes to enhance gene transfer
|
|
US7119172B2
(en)
|
2001-05-21 |
2006-10-10 |
The Brigham And Women's Hospital, Inc. |
P. aeruginosa mucoid exopolysaccharide specific binding peptides
|
|
US6962813B2
(en)
|
2001-05-21 |
2005-11-08 |
The Brigham And Women's Hospital, Inc. |
P. aeruginosa mucoid exopolysaccharide specific binding peptides
|
|
AU2002351208A1
(en)
|
2001-12-03 |
2003-06-17 |
Abgenix, Inc. |
Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
|
|
JP2005532415A
(ja)
|
2001-12-11 |
2005-10-27 |
メルク エンド カムパニー インコーポレーテッド |
スタフィロコッカス・アウレウスエキソポリサッカライド及び方法
|
|
CA2471849A1
(en)
*
|
2001-12-28 |
2003-07-17 |
Abgenix, Inc. |
Antibodies against the muc18 antigen
|
|
EP1532175B1
(en)
|
2002-03-22 |
2012-10-17 |
Aprogen, Inc. |
Humanized antibody and process for preparing the same
|
|
CA2480052A1
(en)
|
2002-04-01 |
2003-10-16 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to gmad
|
|
DE10228103A1
(de)
|
2002-06-24 |
2004-01-15 |
Bayer Cropscience Ag |
Fungizide Wirkstoffkombinationen
|
|
AU2003279308A1
(en)
|
2002-11-04 |
2004-06-07 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a)
|
|
AU2003290867A1
(en)
*
|
2002-11-12 |
2004-06-03 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating staphylococcal infections
|
|
WO2004043405A2
(en)
*
|
2002-11-12 |
2004-05-27 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
US7563748B2
(en)
|
2003-06-23 |
2009-07-21 |
Cognis Ip Management Gmbh |
Alcohol alkoxylate carriers for pesticide active ingredients
|
|
AU2005236068C1
(en)
|
2004-04-21 |
2012-08-30 |
Beth Israel Deaconess Medical Center, Inc. |
Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
|
|
US8510225B2
(en)
|
2004-09-01 |
2013-08-13 |
Research In Motion Limited |
Split channel authenticity queries in multi-party dialog
|
|
EP2410044B1
(en)
|
2004-12-29 |
2022-06-22 |
Hadasit Medical Research Services And Development Ltd. |
Stem cells culture systems
|
|
AR060187A1
(es)
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
|
KR20110031393A
(ko)
|
2008-07-21 |
2011-03-25 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
|
|
US8454979B2
(en)
|
2009-02-20 |
2013-06-04 |
Meisho Co., Ltd. |
Immunopotentiating composition and process for producing same
|
|
WO2012099805A2
(en)
|
2011-01-19 |
2012-07-26 |
Ocean Nanotech, Llc |
Nanoparticle based immunological stimulation
|
|
EP2854822B1
(en)
|
2012-05-30 |
2020-07-22 |
The Brigham and Women's Hospital, Inc. |
Polysaccharide compositions and methods of use
|
|
US9759721B2
(en)
|
2013-01-22 |
2017-09-12 |
Imicroq, S.L. |
Rapid method for detection of pathogen
|